Biopharma Innovation Provides Value For Money In Developing Countries, IFPMA Says
This article was originally published in PharmAsia News
Executive Summary
Improved diagnosis and treatment that will lead to the use of innovative therapies can help lower health care costs in developing and middle-income countries such as China, according to an IFPMA study.